Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients
Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Park
| Condition(s) | Parkinson Disease |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson\'s patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated. |
| Who can participate | Inclusion Criteria: * Hoehn \& Yahr staging ≤3 points, * Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months, * Those with full upper extremity shoulder flexion and abduction active joint range of motion. Exclusion Criteria: * Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension, * People with any orthopedic problem that will affect the upper extremity, * Having a secondary neurological disease diagnosis, * Having vision impairment that may affect measurement methods (not corrected by glasses), * Having a cognitive disease that may cause difficulty in following the researchers\' commands, * Those who had changes in their medical use during the test (dose increase/decrease, drug change |
| Ages | 45 Years to 75 Years |
| Sex | All |
| Lead sponsor | Emre Şenocak |
| Locations | Istanbul, Turkey (Türkiye) |
| Start date | 2024-05-20 |
| NCT ID | NCT06482502 |
| Official listing | https://clinicaltrials.gov/study/NCT06482502 |